4363-s SNX-482
- Code:
- 4363-s
- Name:
- SNX-482
- Gly-Val-Asp-Lys-Ala-Gly-Cys-Arg-Tyr-Met-Phe-Gly-Gly-Cys-Ser-Val-Asn-Asp-Asp-Cys-Cys-Pro-Arg-Leu-Gly-Cys-His-Ser-Leu-Phe-Ser-Tyr-Cys-Ala-Trp-Asp-Leu-Thr-Phe-Ser-Asp (Disulfide bonds between Cys7-Cys21, Cys14-Cys26, and Cys20-Cys33)
- (M.W. 4495.0) C192H274N52O60S7
- Class E (R-type) Ca2+ Channel Blocker
Package | Price(Yen) |
---|---|
Vial 0.1 mg | 30,000 |
- main
- more information
- reference
main
- Purity:
- ≧98.0% (HPLC)
- Storage:
- -20 ℃
- Source:
- Tarantula, Hysterocrates gigas
- Production:
- Synthetic Product
Solubility: 0.02% NH4OH (0.1 mM)
more information
- CAS Registry Number:
- 203460-30-4
- Category:
- Biologically Active Peptides
reference
- R. Newcomb, B. Szoke, A. Palma, G. Wang, X.-h. Chen, W. Hopkins, R. Cong, J. Miller, L. Urge, K. Tarczy-Hornoch, J.A. Loo, D.J. Dooley, L. Nadasdi, R. W. Tsien, J. Lemos, and G. Miljanich, Biochemistry, 37, 15353 (1998). (Original)
- L. Ürge, B. Szöke, D. Silva, P. Tran-Tau, D. Hom, K. Tarczy-Hornoch, and L. Nádasdi, Peptides 1998, (S. Bajusz and F. Hudecz, eds.), pp.748-749 (1999). (S-S Bond)
- A. Tottene, S. Volsen, and D. Pietrobon, J. Neurosci., 20, 171 (2000). (Pharmacol.)
- G. Wang, G. Dayanithi, R. Newcomb, and J. R. Lemos, J. Neurosci., 19, 9235 (1999). (Pharmacol.)
- D. Sochivko, A. Pereverzev, N. Smyth, C. Gissel, T. Schneider, and H. Beck, J. Physiol., 542, 699 (2002). (Pharmacol.)
- X. Jing, D.-Q. Li, C.S. Olofsson, A. Salehi, V.V. Surve, J. Caballero, R. Ivarsson, I. Lundquist, A. Pereverzev, T. Schneider, P. Rorsman, and E. Renström, J. Clin. Invest., 115, 146 (2005). (Pharmacol.)